Cargando…

Made from concentrate? A national web survey assessing dab use in the United States

BACKGROUND: Cannabis concentrates, including dabs, contain extremely high levels of Δ(9)-tetrahydrocannabinol (THC). Although these products appear to be gaining popularity among recreational cannabis consumers, little data exists regarding concentrate use in the US. We conducted a national web-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagar, Kelly A., Lambros, Ashley M., Dahlgren, Mary Kathryn, Smith, Rosemary T., Gruber, Staci A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036911/
https://www.ncbi.nlm.nih.gov/pubmed/30029166
http://dx.doi.org/10.1016/j.drugalcdep.2018.05.022
_version_ 1784693617913233408
author Sagar, Kelly A.
Lambros, Ashley M.
Dahlgren, Mary Kathryn
Smith, Rosemary T.
Gruber, Staci A.
author_facet Sagar, Kelly A.
Lambros, Ashley M.
Dahlgren, Mary Kathryn
Smith, Rosemary T.
Gruber, Staci A.
author_sort Sagar, Kelly A.
collection PubMed
description BACKGROUND: Cannabis concentrates, including dabs, contain extremely high levels of Δ(9)-tetrahydrocannabinol (THC). Although these products appear to be gaining popularity among recreational cannabis consumers, little data exists regarding concentrate use in the US. We conducted a national web-based survey to examine patterns of concentrate use, specifically dabbing. METHODS: 4077 respondents completed a survey designed to assess the use of conventional flower cannabis relative to dabs. Individuals provided information about frequency and magnitude of use, and also completed the Marijuana Motives Measure and Severity of Dependence Scale to examine whether dab users have different motives for use and/or demonstrate more severe consequences of use compared to those who only use conventional flower products. RESULTS: 58% of respondents reported they had tried dabs at least once and 36.5% endorsed regular use (once a month or more). Those who use regularly use dabs were significantly more likely to report using for experimentation (feeling “curious”) relative to reasons for using conventional flower products. Interestingly, motives reflecting positive effects (i.e., coping, sleep problems, relieving social anxiety) were endorsed more highly for flower use. In addition, regular dab users reported being more worried about their use of cannabis products relative to those who had tried dabs but did not use regularly. CONCLUSIONS: Results indicate that cannabis consumers do not necessarily choose dabs over flower products for positive effects, but rather appear to choose these highly potent products for experimentation. As concentrate use may lead to increased cannabis-related problems, studies directly assessing concentrate users are needed.
format Online
Article
Text
id pubmed-9036911
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-90369112022-04-25 Made from concentrate? A national web survey assessing dab use in the United States Sagar, Kelly A. Lambros, Ashley M. Dahlgren, Mary Kathryn Smith, Rosemary T. Gruber, Staci A. Drug Alcohol Depend Article BACKGROUND: Cannabis concentrates, including dabs, contain extremely high levels of Δ(9)-tetrahydrocannabinol (THC). Although these products appear to be gaining popularity among recreational cannabis consumers, little data exists regarding concentrate use in the US. We conducted a national web-based survey to examine patterns of concentrate use, specifically dabbing. METHODS: 4077 respondents completed a survey designed to assess the use of conventional flower cannabis relative to dabs. Individuals provided information about frequency and magnitude of use, and also completed the Marijuana Motives Measure and Severity of Dependence Scale to examine whether dab users have different motives for use and/or demonstrate more severe consequences of use compared to those who only use conventional flower products. RESULTS: 58% of respondents reported they had tried dabs at least once and 36.5% endorsed regular use (once a month or more). Those who use regularly use dabs were significantly more likely to report using for experimentation (feeling “curious”) relative to reasons for using conventional flower products. Interestingly, motives reflecting positive effects (i.e., coping, sleep problems, relieving social anxiety) were endorsed more highly for flower use. In addition, regular dab users reported being more worried about their use of cannabis products relative to those who had tried dabs but did not use regularly. CONCLUSIONS: Results indicate that cannabis consumers do not necessarily choose dabs over flower products for positive effects, but rather appear to choose these highly potent products for experimentation. As concentrate use may lead to increased cannabis-related problems, studies directly assessing concentrate users are needed. 2018-09-01 2018-06-26 /pmc/articles/PMC9036911/ /pubmed/30029166 http://dx.doi.org/10.1016/j.drugalcdep.2018.05.022 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Sagar, Kelly A.
Lambros, Ashley M.
Dahlgren, Mary Kathryn
Smith, Rosemary T.
Gruber, Staci A.
Made from concentrate? A national web survey assessing dab use in the United States
title Made from concentrate? A national web survey assessing dab use in the United States
title_full Made from concentrate? A national web survey assessing dab use in the United States
title_fullStr Made from concentrate? A national web survey assessing dab use in the United States
title_full_unstemmed Made from concentrate? A national web survey assessing dab use in the United States
title_short Made from concentrate? A national web survey assessing dab use in the United States
title_sort made from concentrate? a national web survey assessing dab use in the united states
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036911/
https://www.ncbi.nlm.nih.gov/pubmed/30029166
http://dx.doi.org/10.1016/j.drugalcdep.2018.05.022
work_keys_str_mv AT sagarkellya madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates
AT lambrosashleym madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates
AT dahlgrenmarykathryn madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates
AT smithrosemaryt madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates
AT gruberstacia madefromconcentrateanationalwebsurveyassessingdabuseintheunitedstates